Jiaqi Mei

Jiangsu Ocean University

H指数:14

被引数:513

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target

胆固醇代谢重编程驱动弥漫大B细胞淋巴瘤的发生，并代表一个有前景的治疗靶点

Frontiers in Cell and Developmental Biology

IF4.3

2025-09-260

OAAI

Edge-preserving smoothing using the truncated ℓp minimization

基于截断ℓp最小化的边缘保持平滑

signal processing image communication

IF0

2025-06-250

PRE

Comprehensive analysis of plasma cell heterogeneity and immune interactions in multiple myeloma

多发性骨髓瘤中浆细胞异质性与免疫相互作用的综合分析

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-04-220

Developing a highly efficient 4-hydroxyphenylacetate-3-hydroxylase for salvianic acid A synthesis by computer-aided molecular modification

通过计算机辅助分子修饰开发用于 salvianic acid A 合成的超高效 4-羟基苯乙酸-3-羟化酶

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2025-04-010

PRE

High-ammonia microenvironment promotes stemness and metastatic potential in hepatocellular carcinoma through metabolic reprogramming

高氨微环境通过代谢重编程促进肝细胞癌的干性及转移潜能

DISCOVER ONCOLOGY

IF2.9

2025-02-140

Contrast-preserving image smoothing via the truncated first-order rational function

SIGNAL PROCESSING

IF3.6

2025-02-010

PRE

SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system

SGLT2抑制剂: 通过对神经系统的多方面影响治疗认知障碍的新方法

TRANSLATIONAL NEURODEGENERATION

IF15.2

2024-08-092

OAAI

Development of a predictive machine learning model for pathogen profiles in patients with secondary immunodeficiency

开发用于继发性免疫缺陷患者病原体谱的预测机器学习模型

BMC MEDICAL INFORMATICS AND DECISION MAKING

IF3.8

2024-02-133

OAAI

Efficacy and safety of camrelizumab combined with albumin-bound paclitaxel as third- or later-line regimen in patients with advanced non-small cell lung cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-12-060

OAAI

Engineering of 4-hydroxyphenylacetate-3-hydroxylase from Escherichia coli for efficient biosynthesis of piceatannol

PROCESS BIOCHEMISTRY

IF4

2023-12-013

PRE

Pocket Modification of co-Amine Transaminase AtATA for Overcoming the Trade-Off Between Activity and Stability Toward 1-Acetonaphthone

ENGINEERING

IF11.6

2023-11-013

OAAI

Advances in 4-Hydroxyphenylacetate-3-hydroxylase Monooxygenase

MOLECULES

IF4.6

2023-09-195

OAAI

Modification of the 4-Hydroxyphenylacetate-3-hydroxylase Substrate Pocket to Increase Activity towards Resveratrol

MOLECULES

IF4.6

2023-07-247

OAAI

Enhancing the organic solvent resistance of ω-amine transaminase for enantioselective synthesis of (R)-(+)-1(1-naphthyl)-ethylamine

BIOTECHNOLOGY JOURNAL

IF3.1

2023-07-097

PRE

Turning thermostability of Aspergillus terreus (R)-selective transaminase At-ATA by synthetic shuffling

JOURNAL OF BIOTECHNOLOGY

IF3.9

2023-02-011

PRE

Understanding the mechanism of enhanced alcoholysis of biomass carbohydrates to alkyl levulinates over bifunctional catalysts: does it resemble that in water?

GREEN CHEMISTRY

IF9.2

2023-01-017

PRE

RETRACTED: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ∧(125)I particles in the treatment of esophageal cancer (Retracted Article)

FRONTIERS IN ONCOLOGY

IF3.3

2022-12-061

High level production of γ-aminobutyric acid in engineered Escherichia coli by refactoring the glutamate decarboxylase

PROCESS BIOCHEMISTRY

IF4

2022-07-014

PRE

Reconstruction of the glutamate decarboxylase system in Lactococcus lactis for biosynthesis of food-grade γ-aminobutyric acid

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

IF4.3

2021-05-1516

PREAI

Improvement of γ-aminobutyrate biosynthesis by genetically engineered Lactococcus lactis

BIOCHEMICAL ENGINEERING JOURNAL

IF3.8

2020-04-0117

PREAI

Jiaqi Mei

个人简介

教育背景

工作经历

荣誉奖项

研究方向